For patients with clear-cell renal cell carcinoma, pembrolizumab-belzutifan yields significantly higher disease-free survival, according to a study published in the July 2 issue…
Continue Reading
News Source: medicalxpress.com
Pembrolizumab-belzutifan tied to improved disease-free survival in renal cell carcinoma
Leave a Reply